![Bertrand Delsuc on Twitter: "AbbVie $ABBV upadacitinib (oral JAK1i) in CD - CELEST study #ECCO18 https://t.co/QkWKXzzbKb https://t.co/uDuNljBrSN" / Twitter Bertrand Delsuc on Twitter: "AbbVie $ABBV upadacitinib (oral JAK1i) in CD - CELEST study #ECCO18 https://t.co/QkWKXzzbKb https://t.co/uDuNljBrSN" / Twitter](https://pbs.twimg.com/media/DVn1I0CVwAAVbci.jpg)
Bertrand Delsuc on Twitter: "AbbVie $ABBV upadacitinib (oral JAK1i) in CD - CELEST study #ECCO18 https://t.co/QkWKXzzbKb https://t.co/uDuNljBrSN" / Twitter
![Review of the 17th Congress of the European Crohn's and Colitis Organisation (ECCO) - European Medical Journal Review of the 17th Congress of the European Crohn's and Colitis Organisation (ECCO) - European Medical Journal](https://www.emjreviews.com/wp-content/uploads/2022/03/Feature-Image-Gastroenterology-11-Supplement-1-ECCO-940x563.jpg)
Review of the 17th Congress of the European Crohn's and Colitis Organisation (ECCO) - European Medical Journal
![ECCO Shoes Store in a Siam Paragon Mall in Bangkok, Thailand. ECCO Storefront Editorial Stock Image - Image of fashion, boutique: 205951004 ECCO Shoes Store in a Siam Paragon Mall in Bangkok, Thailand. ECCO Storefront Editorial Stock Image - Image of fashion, boutique: 205951004](https://thumbs.dreamstime.com/z/ecco-shoes-store-siam-paragon-mall-bangkok-thailand-ecco-storefront-ecco-danish-shoe-manufacturer-retailer-205951004.jpg)
ECCO Shoes Store in a Siam Paragon Mall in Bangkok, Thailand. ECCO Storefront Editorial Stock Image - Image of fashion, boutique: 205951004
Tauseef Ali MD, FACG AGAF FACP on Twitter: "Sunday Review #IBD101 Withdrawal versus continuation of thiopurine in vedolizumab-treated patients with Ulcerative Colitis (VIEWS): a multi-centre randomised controlled trial https://t.co/KPVL2TcKX9" / Twitter
![PDF) Young adults living with inflammatory bowel disease. A thematic synthesis of patient experience. PDF) Young adults living with inflammatory bowel disease. A thematic synthesis of patient experience.](https://i1.rgstatic.net/publication/325952662_Young_adults_living_with_inflammatory_bowel_disease_A_thematic_synthesis_of_patient_experience/links/5b2ea8854585150d23caa253/largepreview.png)
PDF) Young adults living with inflammatory bowel disease. A thematic synthesis of patient experience.
![European Crohn´s and Colitis Organisation - ECCO - Submit your congress abstract and share your research and clinical developments European Crohn´s and Colitis Organisation - ECCO - Submit your congress abstract and share your research and clinical developments](https://ecco-ibd.eu/images/Wladyslawa_Czuber-Dochan_2018.jpg)
European Crohn´s and Colitis Organisation - ECCO - Submit your congress abstract and share your research and clinical developments
![PDF) 4th Congress of ECCO Inflammatory Bowel Diseases Impact of antiTNF treatment on Extraintestinal Manifestations in Patients with Inflammatory Bowel Disease: real world data in Germany PDF) 4th Congress of ECCO Inflammatory Bowel Diseases Impact of antiTNF treatment on Extraintestinal Manifestations in Patients with Inflammatory Bowel Disease: real world data in Germany](https://i1.rgstatic.net/publication/337008399_4th_Congress_of_ECCO_-_Inflammatory_Bowel_Diseases_Impact_of_anti-TNF_treatment_on_Extra-intestinal_Manifestations_in_Patients_with_Inflammatory_Bowel_Disease_real_world_data_in_Germany/links/5dc01db392851c818028b1a3/largepreview.png)
PDF) 4th Congress of ECCO Inflammatory Bowel Diseases Impact of antiTNF treatment on Extraintestinal Manifestations in Patients with Inflammatory Bowel Disease: real world data in Germany
![Bertrand Delsuc on Twitter: "AbbVie $ABBV upadacitinib (oral JAK1i) in CD - CELEST study #ECCO18 https://t.co/QkWKXzzbKb https://t.co/uDuNljBrSN" / Twitter Bertrand Delsuc on Twitter: "AbbVie $ABBV upadacitinib (oral JAK1i) in CD - CELEST study #ECCO18 https://t.co/QkWKXzzbKb https://t.co/uDuNljBrSN" / Twitter](https://pbs.twimg.com/media/DVn1ixWV4AAr0Yo.jpg)
Bertrand Delsuc on Twitter: "AbbVie $ABBV upadacitinib (oral JAK1i) in CD - CELEST study #ECCO18 https://t.co/QkWKXzzbKb https://t.co/uDuNljBrSN" / Twitter
![ECCO: Improving outcomes for all cancer patients in Europe through multidisciplinarity - Research Outreach ECCO: Improving outcomes for all cancer patients in Europe through multidisciplinarity - Research Outreach](https://researchoutreach.org/wp-content/uploads/2018/06/158_20150925_new-1200x675.jpg)
ECCO: Improving outcomes for all cancer patients in Europe through multidisciplinarity - Research Outreach
![PDF) Abstract: OP036 Short duration, low intensity pooled faecal microbiota transplantation induces remission in patients with mild-moderately active ulcerative colitis: a randomised controlled trial PDF) Abstract: OP036 Short duration, low intensity pooled faecal microbiota transplantation induces remission in patients with mild-moderately active ulcerative colitis: a randomised controlled trial](https://i1.rgstatic.net/publication/313467511_Abstract_OP036_Short_duration_low_intensity_pooled_faecal_microbiota_transplantation_induces_remission_in_patients_with_mild-moderately_active_ulcerative_colitis_a_randomised_controlled_trial/links/5a78e938aca2722e4df31b42/largepreview.png)
PDF) Abstract: OP036 Short duration, low intensity pooled faecal microbiota transplantation induces remission in patients with mild-moderately active ulcerative colitis: a randomised controlled trial
The First European Evidence-based Consensus on Extra-intestinal Manifestations in Inflammatory Bowel Disease
![PDF) DOP028 Second N-ECCO Consensus Statements on the European nursing roles in caring for patients with Crohn's disease or ulcerative colitis PDF) DOP028 Second N-ECCO Consensus Statements on the European nursing roles in caring for patients with Crohn's disease or ulcerative colitis](https://i1.rgstatic.net/publication/322890443_DOP028_Second_N-ECCO_Consensus_Statements_on_the_European_nursing_roles_in_caring_for_patients_with_Crohn's_disease_or_ulcerative_colitis/links/5c7fc64592851c69505a7e20/largepreview.png)